BOAN BIOTECH (06955) completes placement of 48 million shares, raising approximately HK$780 million net.
Boson Biotech (06955) announces that the allocation will be completed on August 14, 2025. A total of 480...
BOAN BIOTECH (06955) announced that the placement matters were completed on August 14, 2025. A total of 48 million new shares (equivalent to approximately 7.71% of the total issued shares after the placement and issuance of new shares) were placed at a price of HK$16.42 per share to no less than six subscribers. The net proceeds received by the company from the placement amount to approximately HK$780 million.
Related Articles
Silver Promise Medicine-B (02591) skyrocketed 270% in the dark market, attracting market attention to the GLP-1 track, while PEGBIO CO-B (02565) promising growth in undervalued areas.
US Stock Market Move | The profit outlook for the fiscal year 2026 is below expectations. Tapestry (TPR.US) fell more than 13%.
Golden jewelry investment leaders: CHOW TAI FOOK (01929) and LAOPU GOLD (06181), the growth logic behind the "buy" rating.
Silver Promise Medicine-B (02591) skyrocketed 270% in the dark market, attracting market attention to the GLP-1 track, while PEGBIO CO-B (02565) promising growth in undervalued areas.
US Stock Market Move | The profit outlook for the fiscal year 2026 is below expectations. Tapestry (TPR.US) fell more than 13%.
Golden jewelry investment leaders: CHOW TAI FOOK (01929) and LAOPU GOLD (06181), the growth logic behind the "buy" rating.
